## **Core Concept**
Cisapride is a gastroprokinetic agent that enhances gastrointestinal motility. It acts by increasing the release of acetylcholine in the gastrointestinal tract, which leads to enhanced gut motility. This action is beneficial in treating conditions like gastroesophageal reflux disease (GERD) and diabetic gastroparesis.

## **Why the Correct Answer is Right**
The correct answer, **D. 5-HT4 agonist**, is right because cisapride exerts its gastroprokinetic effects primarily by acting as an agonist at the 5-HT4 receptor. This receptor is found in the gastrointestinal tract and, when stimulated, increases the release of acetylcholine from the myenteric plexus, thereby enhancing gastrointestinal motility. This mechanism helps in accelerating gastric emptying and improving lower esophageal sphincter tone.

## **Why Each Wrong Option is Incorrect**
- **Option A:** This option is incorrect because cisapride's mechanism does not primarily involve antagonizing dopamine receptors, which is a mechanism more commonly associated with drugs like metoclopramide.
- **Option B:** This option is incorrect as cisapride does not act as a direct muscarinic receptor agonist. Instead, it works indirectly by enhancing acetylcholine release.
- **Option C:** This option is incorrect because cisapride's action is not primarily through prostaglandin pathways.

## **Clinical Pearl / High-Yield Fact**
A key point to remember about cisapride is that, despite its efficacy as a gastroprokinetic agent, it was withdrawn from many markets due to concerns over cardiac arrhythmias, specifically QT interval prolongation, which could lead to serious heart rhythm disturbances. This highlights the importance of considering the safety profile of drugs in addition to their mechanism of action and efficacy.

## **Correct Answer:** D. 5-HT4 agonist